ENOV
Enovis Corporation
ENOV lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
ENOV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Healthy |
ENOV's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ENOV PE Valuation
ENOV has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
ENOV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ENOV, with profitability improving.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ENOV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.56 | — |
| Q3 2026 | -$9.25 | +$15.05 |
| Q2 2026 | -$19.30 | -$4.41 |
| Q1 2026 | -$19.92 | -$5.33 |
| Q4 2025 | -$20.75 | -$5.82 |
| Q3 2025 | -$24.30 | -$22.11 |
| Q2 2025 | -$14.89 | -$13.23 |
| Q1 2025 | -$14.59 | -$13.09 |
| Q4 2024 | -$14.93 | -$14.32 |
ENOV has the stronger earnings trend. Trailing diluted EPS is down 138% for ENOV versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
ENOV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $558.7M | +1.8% |
| Q2 2026 | $582.8M | +3.2% |
| Q1 2026 | $589.2M | +5.4% |
| Q4 2025 | $575.8M | +2.6% |
| Q3 2025 | $548.9M | +8.6% |
| Q2 2025 | $564.5M | +7.5% |
| Q1 2025 | $558.8M | +8.2% |
| Q4 2024 | $561M | +23% |
ENOV's revenue has grown year over year for 14 quarters in a row: $559M last quarter, up 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.6% | +102 points |
| Q2 2026 | 3% | +6 points |
| Q1 2026 | 1.1% | +9.5 points |
| Q4 2025 | -87% | +31 points |
| Q3 2025 | -102% | -96 points |
| Q2 2025 | -3% | +5.4 points |
| Q1 2025 | -8.4% | -1.6 points |
| Q4 2024 | -119% | -117 points |
ENOV has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over ENOV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
ENOV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $35M | +20% |
| Q2 2026 | $31.1M | +816% |
| Q1 2026 | -$28.9M | +$16M |
| Q4 2025 | $32.3M | -8.1% |
| Q3 2025 | $29.1M | +1128% |
| Q2 2025 | $3.4M | +$35M |
| Q1 2025 | -$44.9M | +$28.2M |
| Q4 2024 | $35.1M | -13% |
ENOV has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
ENOV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +892K shares |
| 1 year | +2.3% | +1.3M shares |
| 3 years | +7.2% | +3.9M shares |
| 5 years | +8.9% | +4.8M shares |
| Available history | +28% | +12.9M shares |
ENOV has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
ENOV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 5.7x | High |
| Q2 2025 | 7.9x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 8.4x | High |
| Q3 2024 | 8.7x | High |
ENOV's net debt is about 1.4 years of its operating earnings (EBITDA), down from 7.9 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ENOV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.6 | Neutral |
| Stochastic | 58.1 | Neutral |
ENOV's weekly RSI is 61 (neutral) and its Stochastic is 58 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ENOV PE vs Industrials Sector
| Metric | ENOV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ENOV has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
ENOV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 31% above |
| 20 week MA | $23.0 | 20% above |
| 50 week MA | $23.7 | 17% above |
| 100 week MA | $29.2 | 5.2% below |
| 200 week MA | $41.1 | 33% below |
ENOV has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
ENOV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $63.3 | +1.4% |
| 2021 | $63.3 | $77.7 | +23% |
| 2022 | $77.7 | $52.9 | -32% |
| 2023 | $52.9 | $56.0 | +6% |
| 2024 | $56.0 | $44.3 | -21% |
| 2025 | $44.3 | $27.4 | -38% |
| 2026 YTD | $27.4 | $27.6 | +0.9% |
ENOV has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.